- A Case of Rosai-Dorfman Disease with Highly Elevated Serum Ferritin
-
Rew SY, Jang HC, Park KH, Ahn JS, Kim GE, Choi YD, Jung SI
- KMID: 1245257
- Ann Lab Med.
- 2012 Mar;32(2):158-161.
- doi: 10.3343/alm.2012.32.2.158
Sinus histiocytosis with massive lymphadenopathy, also known as Rosai-Dorfman disease is a rare disorder characterized by proliferation of distinctive histiocytes within lymph node sinuses and lymphatics, sometimes involving extranodal sites.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Autoimmune Hemolytic Anemia Caused by Repeated Administration of Oxaliplatin
-
Kim DE, Cho DH, Rew SY, Hwang JE, Bae WK, Shim HJ, Chung IJ
- KMID: 1730011
- Chonnam Med J.
- 2010 Aug;46(2):125-128.
- doi: 10.4068/cmj.2010.46.2.125
Oxaliplatin is widely used as a chemotherapeutic agent for treating unresectable or metastatic gastrointestinal tract cancer, such as gastric cancer and colorectal cancer. The toxic effects commonly associated with oxaliplatin... -
- CITED
-
- Close
- SHARE
-
- Close
- Toxic Epidermal Necrolysis after Rituximab Therapy for Immune Thrombocytopenic Purpura
-
Bae SY, Kim YK, Yoon JY, Lee SJ, Kim DE, Rew SY, Hong SD, Jo DH, Hwang JI, Bae WK, Shim HJ, Ahn JS, Yang DH, Cho SH, Lee JJ, Chung IJ, Kim HJ
- KMID: 2252156
- Korean J Hematol.
- 2009 Jun;44(2):108-112.
- doi: 10.5045/kjh.2009.44.2.108
Rituximab is a chimeric monoclonal antibody that specifically targets the CD20 molecule on the B cell surface. Although rituximab was originally introduced for the treatment of lymphoid neoplasms such as... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy according to Dexamethasone Dose in Combination with Aprepitant and Granisetron during Cisplatin-based Chemotherapy
-
Cho DH, Kim DE, Rew SY, Hong SD, Yoon JY, Hwang JE, Bae WK, Shim HJ, Cho SH, Chung IJ
- KMID: 1730004
- Chonnam Med J.
- 2010 Aug;46(2):88-93.
- doi: 10.4068/cmj.2010.46.2.88
The purpose of this study was to evaluate the dosage of dexamethasone in combination with granisetron and aprepitant when used for the prevention of acute and delayed nausea and vomiting... -
- CITED
-
- Close
- SHARE
-
- Close
- Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma
-
Ahn JS, Rew SY, Yang DH, Jung SH, Kang SJ, Kim MY, Lee SS, Kim YK, Kim HJ, Lee JJ
- KMID: 2270724
- Blood Res.
- 2013 Mar;48(1):35-39.
- doi: 10.5045/br.2013.48.1.35
BACKGROUND: Bortezomib administration leads to a transient decrease in CD4+ T cells, increasing the susceptibility to opportunistic infections. The activation and proliferation of CD4+ T cells are particularly important in... -
- CITED
-
- Close
- SHARE
-
- Close
- Reporting and Clinical Features of Adverse Drug Reactions from a Single University Hospital
-
- KMID: 2299500
- Korean J Asthma Allergy Clin Immunol.
- 2011 Sep;31(3):184-191.
BACKGROUND: Since introduction of regional pharmacovigilance centers in Korea, the number of domestic adverse drug reactions (ADRs) reported is rapidly increasing. However, there have been only a few reports on... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Irinotecan, High-dose 5-fluorouracil, and Leucovorin Combination Chemotherapy in Taxane and Cisplatin-based Chemotherapy-refractory Metastatic Gastric Cancer
-
Yoon JY, Lee SJ, Cho DH, Rew SY, Kim DE, Hwang JE, Bae WK, Shim HJ, Cho SH, Chung IJ
- KMID: 2172265
- Chonnam Med J.
- 2009 Aug;45(2):79-86.
- doi: 10.4068/cmj.2009.45.2.79
This phase II study evaluated the efficacy and safety of combination chemotherapy with irinotecan, high-dose 5-fluorouracil (5-FU), and leucovorin as a second line of treatment in metastatic gastric cancer refractory... -
- CITED
-
- Close
- SHARE
-
- Close
